915 related articles for article (PubMed ID: 30509194)
1. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
[TBL] [Abstract][Full Text] [Related]
2. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M;
BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203
[TBL] [Abstract][Full Text] [Related]
3. Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
Day MJ; Jacobsson S; Spiteri G; Kulishev C; Sajedi N; Woodford N; Blumel B; van der Werf MJ; Amato-Gauci AJ; Unemo M; Cole MJ;
BMC Infect Dis; 2022 Jun; 22(1):524. PubMed ID: 35672671
[TBL] [Abstract][Full Text] [Related]
4. The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.
Cole MJ; Quinten C; Jacobsson S; Day M; Amato-Gauci AJ; Woodford N; Spiteri G; Unemo M;
BMC Infect Dis; 2019 Dec; 19(1):1040. PubMed ID: 31822275
[TBL] [Abstract][Full Text] [Related]
5. Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.
Jacobsson S; Cole MJ; Spiteri G; Day M; Unemo M;
BMC Infect Dis; 2021 Mar; 21(1):273. PubMed ID: 33736608
[TBL] [Abstract][Full Text] [Related]
6. Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.
Cole MJ; Spiteri G; Chisholm SA; Hoffmann S; Ison CA; Unemo M; Van de Laar M
Euro Surveill; 2014 Nov; 19(45):20955. PubMed ID: 25411689
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019.
Aniskevich A; Shimanskaya I; Boiko I; Golubovskaya T; Golparian D; Stanislavova I; Jacobsson S; Adaskevich A; Unemo M
BMC Infect Dis; 2021 Jun; 21(1):520. PubMed ID: 34078300
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018.
Boiko I; Golparian D; Krynytska I; Bezkorovaina H; Frankenberg A; Onuchyna M; Jacobsson S; Unemo M
APMIS; 2019 Jul; 127(7):503-509. PubMed ID: 30903707
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance in
Hernando Rovirola C; Spiteri G; Sabidó M; Montoliu A; Gonzalez V; Casabona J; Cole MJ; Noori T; Unemo M
Sex Transm Infect; 2020 May; 96(3):204-210. PubMed ID: 32019895
[TBL] [Abstract][Full Text] [Related]
10. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
[TBL] [Abstract][Full Text] [Related]
11. Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance.
Cole MJ; Spiteri G; Jacobsson S; Pitt R; Grigorjev V; Unemo M;
BMC Infect Dis; 2015 Aug; 15():321. PubMed ID: 26259560
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
[TBL] [Abstract][Full Text] [Related]
13. Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012.
Kubanova A; Kubanov A; Frigo N; Solomka V; Semina V; Vorobyev D; Khairullin R; Unemo M
BMC Infect Dis; 2014 Jun; 14():342. PubMed ID: 24947981
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility in
Latif AS; Gwanzura L; Machiha A; Ndowa F; Tarupiwa A; Gudza-Mugabe M; Shukusho FD; Chakanyuka Musanhu C; Wi T; Unemo M
Sex Transm Infect; 2018 Feb; 94(1):62-66. PubMed ID: 28476914
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in Kampala, Uganda (2008-2009).
Vandepitte J; Hughes P; Matovu G; Bukenya J; Grosskurth H; Lewis DA
Sex Transm Dis; 2014 Apr; 41(4):233-7. PubMed ID: 24622633
[TBL] [Abstract][Full Text] [Related]
16. The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP)--a sentinel approach in the European Union (EU)/European Economic Area (EEA).
Spiteri G; Cole M; Unemo M; Hoffmann S; Ison C; van de Laar M
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv16-8. PubMed ID: 24243874
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial-resistant Neisseria gonorrhoeae in Europe in 2020 compared with in 2013 and 2018: a retrospective genomic surveillance study.
Golparian D; Cole MJ; Sánchez-Busó L; Day M; Jacobsson S; Uthayakumaran T; Abad R; Bercot B; Caugant DA; Heuer D; Jansen K; Pleininger S; Stefanelli P; Aanensen DM; Bluemel B; Unemo M;
Lancet Microbe; 2024 May; 5(5):e478-e488. PubMed ID: 38614111
[TBL] [Abstract][Full Text] [Related]
18. First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015-16.
Bazzo ML; Golfetto L; Gaspar PC; Pires AF; Ramos MC; Franchini M; Ferreira WA; Unemo M; Benzaken AS;
J Antimicrob Chemother; 2018 Jul; 73(7):1854-1861. PubMed ID: 29635367
[TBL] [Abstract][Full Text] [Related]
19. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.
Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ
Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519
[TBL] [Abstract][Full Text] [Related]
20. Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017-2019.
Adamson PC; Van Le H; Le HHL; Le GM; Nguyen TV; Klausner JD
BMC Infect Dis; 2020 Nov; 20(1):809. PubMed ID: 33153450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
